aluminum sulfate has been researched along with Severe Acute Respiratory Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, H; Hashimoto, S; Ishii, K; Itamura, S; Kasai, M; Morikawa, S; Odagiri, T; Ohnishi, K; Ohshima, M; Sakaguchi, M; Takahashi, Y; Takasuka, N; Takemori, T; Tashiro, M; Tsunetsugu-Yokota, Y; Yoshikura, H | 1 |
| Auperin, T; Babiuk, LA; Brunham, RC; Cameron, C; Cochrane, A; Finlay, BB; Kelvin, DJ; Mutwiri, G; Petric, M; Rini, JM; Satkunarajah, M; See, RH; Sharon, C; Viswanathan, S; Zakhartchouk, AN | 1 |
2 other study(ies) available for aluminum sulfate and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibody Formation; Antibody Specificity; Blotting, Western; Immunoglobulin G; Injections, Subcutaneous; Mice; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vaccines, Inactivated; Viral Proteins; Viral Vaccines; Virion | 2004 |
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine.
Topics: Alum Compounds; Animals; Antibodies, Viral; Cell Line; Female; Humans; Interferon-gamma; Membrane Glycoproteins; Mice; Oligodeoxyribonucleotides; Receptors, Virus; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Envelope Proteins; Viral Vaccines | 2007 |